EOJOAM
CRL icon

E. Ohman J:or Asset Management’s Charles River Laboratories CRL Stock Holding History

E. Ohman J:or Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,600
Closed -$480K – 418
2024
Q4 		$480K Buy
2,600
+1,800
+225% +$347K 0.01% 383
2024
Q3 		$158K Buy
+800
New +$166K ﹤0.01% 408
2022
Q4 		– Sell
-2,200
Closed -$433K – 424
2022
Q3 		$433K Buy
+2,200
New +$475K 0.02% 359
2022
Q1 		– Sell
-2,200
Closed -$829K – 433
2021
Q4 		$829K Hold
2,200
– – 0.02% 341
2021
Q3 		$908K Buy
2,200
+300
+16% +$125K 0.03% 310
2021
Q2 		$703K Buy
+1,900
New +$634K 0.02% 357

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return